PT2485583T - Genetically modified mice and engraftment - Google Patents

Genetically modified mice and engraftment

Info

Publication number
PT2485583T
PT2485583T PT108224866T PT10822486T PT2485583T PT 2485583 T PT2485583 T PT 2485583T PT 108224866 T PT108224866 T PT 108224866T PT 10822486 T PT10822486 T PT 10822486T PT 2485583 T PT2485583 T PT 2485583T
Authority
PT
Portugal
Prior art keywords
engraftment
genetically modified
modified mice
mice
genetically
Prior art date
Application number
PT108224866T
Other languages
Portuguese (pt)
Inventor
D Yancopoulos George
J Murphy Andrew
Stevens Sean
Flavell Richard
Eynon Elizabeth
Galan Jorge
Willinger Tim
G Manz Markus
Rongvaux Anthony
Original Assignee
Univ Yale
Regeneron Pharma
Inst For Res In Biomedicine (Irb)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Yale, Regeneron Pharma, Inst For Res In Biomedicine (Irb) filed Critical Univ Yale
Publication of PT2485583T publication Critical patent/PT2485583T/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/524—Thrombopoietin, i.e. C-MPL ligand
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5403—IL-3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/12—Animals modified by administration of exogenous cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0331—Animal model for proliferative diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/0337—Animal models for infectious diseases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0381—Animal model for diseases of the hematopoietic system
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • A01K2267/035—Animal model for multifactorial diseases
    • A01K2267/0387—Animal model for diseases of the immune system
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Environmental Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PT108224866T 2009-10-06 2010-10-04 Genetically modified mice and engraftment PT2485583T (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US24906909P 2009-10-06 2009-10-06
US25623709P 2009-10-29 2009-10-29
US32013210P 2010-04-01 2010-04-01

Publications (1)

Publication Number Publication Date
PT2485583T true PT2485583T (en) 2016-09-22

Family

ID=43857345

Family Applications (3)

Application Number Title Priority Date Filing Date
PT108224866T PT2485583T (en) 2009-10-06 2010-10-04 Genetically modified mice and engraftment
PT16157878T PT3056082T (en) 2009-10-06 2010-10-04 Genetically modified mice and engraftment
PT181839283T PT3417701T (en) 2009-10-06 2010-10-04 Genetically modified mice and engraftment

Family Applications After (2)

Application Number Title Priority Date Filing Date
PT16157878T PT3056082T (en) 2009-10-06 2010-10-04 Genetically modified mice and engraftment
PT181839283T PT3417701T (en) 2009-10-06 2010-10-04 Genetically modified mice and engraftment

Country Status (10)

Country Link
US (7) US8541646B2 (en)
EP (4) EP3417701B1 (en)
JP (5) JP5874881B2 (en)
AU (1) AU2010303737B2 (en)
CA (2) CA2776583C (en)
DK (3) DK3417701T3 (en)
ES (3) ES2591107T3 (en)
HK (1) HK1174783A1 (en)
PT (3) PT2485583T (en)
WO (1) WO2011044050A2 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG176118A1 (en) * 2009-06-29 2011-12-29 Qingfeng Chen Methods of producing humanized non-human mammals
DK3417701T3 (en) 2009-10-06 2022-03-14 Regeneron Pharma GENOMIFICATED MOUSES AND INTAKING
WO2012040207A2 (en) 2010-09-20 2012-03-29 Yale University HUMAM SIRPAα TRANSGENIC ANIMALS AND THEIR METHODS OF USE
EP4233537A3 (en) 2011-02-15 2023-09-13 Regeneron Pharmaceuticals, Inc. Humanized m-csf mice and uses thereof
GB2496375A (en) 2011-10-28 2013-05-15 Kymab Ltd A non-human assay vertebrate comprising human antibody loci and human epitope knock-in, and uses thereof
CN108866101A (en) 2011-10-28 2018-11-23 瑞泽恩制药公司 Humanization IL-6 and IL-6 receptor
GB201122047D0 (en) 2011-12-21 2012-02-01 Kymab Ltd Transgenic animals
EP2788758A4 (en) * 2011-12-06 2015-06-10 Massachusetts Inst Technology Use of humanized mice to determine toxicity
US8962913B2 (en) 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
US20140047572A1 (en) * 2012-08-13 2014-02-13 University Of Rochester Thrombopoietin mimetics for the treatment of radiation or chemical induced bone marrow injury
JP6283031B2 (en) * 2012-09-07 2018-02-21 イエール ユニバーシティ Genetically modified non-human animals and uses thereof
RU2673156C2 (en) * 2012-11-05 2018-11-22 Ридженерон Фармасьютикалз, Инк. Genetically modified non-human animals and methods for use thereof
CN103409468B (en) * 2013-03-20 2015-08-12 中国科学院广州生物医药与健康研究院 A kind of establishment method of immunodeficient mouse model
ES2959333T3 (en) 2013-09-23 2024-02-23 Regeneron Pharma Non-human animals that have a humanized signal regulatory protein gene
KR101552610B1 (en) 2013-09-24 2015-09-18 연세대학교 산학협력단 Animal model for the study of granuloma and method for producing the same
DK3138397T3 (en) 2013-10-15 2019-04-15 Regeneron Pharma Humanized IL-15 animals
MX2016014504A (en) 2014-05-05 2017-05-23 Regeneron Pharma Humanized c5 and c3 animals.
NO2785538T3 (en) 2014-05-07 2018-08-04
AU2015264427B2 (en) 2014-05-19 2021-09-23 Institute For Research In Biomedicine (Irb) Genetically modified non-human animals expressing human EPO
KR102617691B1 (en) 2014-12-05 2023-12-27 리제너론 파마슈티칼스 인코포레이티드 Non-human animals having a humanized cluster of differentiation 47 gene
SI3808775T1 (en) 2014-12-09 2024-08-30 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized cluster of differentiation 274 gene
DK3282835T3 (en) 2015-04-13 2023-06-26 Regeneron Pharma Humanized SIRP?-IL-15 knockin mice and methods of use thereof
EP3673732A3 (en) * 2015-10-27 2020-07-29 Recombinetics, Inc. Engineering of humanized car t-cells and platelets by genetic complementation
BR112018010158A2 (en) 2015-11-20 2018-11-21 Regeneron Pharma rodent, humanized lag-3 polypeptide, cell or tissue, embryonic stem cell and rodent embryo, methods for producing a rodent to evaluate the antitumor efficacy and pharmacokinetic properties of a drug
CN108779159B (en) 2016-02-04 2022-12-30 瑞泽恩制药公司 Non-human animals with engineered ANGPTL8 genes
RU2749715C2 (en) 2016-02-29 2021-06-16 Регенерон Фармасьютикалз, Инк. Rodents characterized by the humanized tmprss gene
US11959925B2 (en) 2017-04-17 2024-04-16 The Jackson Laboratory Method of determining toxicity of an immunomodulatory drug for use in humans
AU2018338790B2 (en) 2017-09-29 2022-09-15 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized TTR locus and methods of use
EP3712266A4 (en) * 2017-11-17 2021-08-18 University of Tsukuba Non-human animal and method for producing same
US20210153484A1 (en) * 2018-04-09 2021-05-27 The Wistar lnstitute Humanized Mouse Model
US11132501B2 (en) * 2018-05-25 2021-09-28 Salesforce.Com, Inc. Smart column selection for table operations in data preparation
SG11202011284RA (en) 2018-07-16 2020-12-30 Regeneron Pharma Non-human animal models of ditra disease and uses thereof
WO2020041174A1 (en) * 2018-08-20 2020-02-27 The Jackson Laboratory Method of determining toxicity of an immunomodulatory drug
CN114206108B (en) 2019-04-04 2023-09-29 瑞泽恩制药公司 Non-human animals comprising a humanized clotting factor 12 locus
WO2020247452A1 (en) 2019-06-04 2020-12-10 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized ttr locus with a beta-slip mutation and methods of use
SG11202111256XA (en) 2019-06-07 2021-11-29 Regeneron Pharma Non-human animals comprising a humanized albumin locus
EP4179080A4 (en) * 2020-07-08 2024-07-17 Jackson Lab Transgenic mouse models supporting human innate immune function
KR20230124973A (en) 2020-12-21 2023-08-28 리제너론 파마슈티칼스 인코포레이티드 Non-human animals having a humanized TSLP gene, a humanized TSLP receptor gene, and/or a humanized IL7RA gene
US20230417899A1 (en) * 2022-06-27 2023-12-28 Oshkosh Corporation Position tracking for a lift device
WO2024020057A1 (en) 2022-07-19 2024-01-25 Regeneron Pharmaceuticals, Inc. Genetically modified animal model and its use to model the human immune system

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870009A (en) 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
US4736866B1 (en) 1984-06-22 1988-04-12 Transgenic non-human mammals
US5573930A (en) 1985-02-05 1996-11-12 Cetus Oncology Corporation DNA encoding various forms of colony stimulating factor-1
WO1988003173A2 (en) 1986-10-24 1988-05-05 Cetus Corporation New forms of colony stimulating factor-1
EP0322240B1 (en) 1987-12-23 1995-03-01 The Board Of Trustees Of The Leland Stanford Junior University Chimeric immunocompromised mammals and their use
JP2981486B2 (en) 1988-06-14 1999-11-22 メディカル・バイオロジー・インスティチュート Mammalian immune system research methods
US5464764A (en) * 1989-08-22 1995-11-07 University Of Utah Research Foundation Positive-negative selection methods and vectors
US5849288A (en) 1990-01-15 1998-12-15 Yeda Research And Development Co. Ltd. Method for production of monoclonal antibodies in chimeric mice or rats having xenogeneic antibody-producing cells
US5652373A (en) 1990-01-15 1997-07-29 Yeda Research And Development Co. Ltd. Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems
EP0438053B1 (en) 1990-01-15 1999-06-16 Yeda Research And Development Company Limited Durable engraftment and development of human hematopoietic lineages in normal mammals
ES2090332T3 (en) 1990-05-03 1996-10-16 Systemix Inc HUMAN LYMPHOID TISSUE IN AN IMMUNOCOMMITTED HOSPITAL.
JPH05500617A (en) 1990-05-25 1993-02-12 システミックス，インコーポレイティド Human peripheral blood cells in immunized hosts
US5633426A (en) 1990-05-25 1997-05-27 Systemix, Inc. In vivo use of human bone marrow for investigation and production
US5222982A (en) 1991-02-11 1993-06-29 Ommaya Ayub K Spinal fluid driven artificial organ
JPH06505186A (en) 1991-02-11 1994-06-16 オマーヤ，アユブ　ケー． Spinal fluid-powered prosthesis
EP0517199A1 (en) 1991-06-04 1992-12-09 Yeda Research And Development Company, Ltd. Durable engraftment of human tissue and cells in normal mammals
WO1993005796A1 (en) 1991-09-19 1993-04-01 The Scripps Research Institute Method for producing human antibodies in a non-human animal, and animals therefor
DE69229254T2 (en) 1991-10-30 1999-09-23 Idemitsu Kosan Co. Ltd., Tokio/Tokyo Processes for the production of human lymphocytes and human antibodies; and antibodies so produced
US6353150B1 (en) 1991-11-22 2002-03-05 Hsc Research And Development Limited Partnership Chimeric mammals with human hematopoietic cells
WO1993018144A1 (en) * 1992-03-05 1993-09-16 The Trustees Of Columbia University Of The City Of New York Recombination activating gene deficient animal
US5866757A (en) 1992-06-02 1999-02-02 Yeda Research And Development Co. Ltd. Engraftment and development of xenogeneic cells in normal mammals having reconstituted hematopoetic deficient immune systems
US6018096A (en) 1993-05-03 2000-01-25 Surrogen, Inc. Animal model for engraftment, proliferation and differentiation of human hematopoietic stem cells
US5663481A (en) 1993-08-06 1997-09-02 Mount Sinai Hospital Corporation Animal model of the human immune system
CA2195678A1 (en) * 1994-07-27 1996-02-08 Joseph A. Borkowski Bradykinin b2 receptor modified transgenic non-human animals
US6455756B1 (en) 1994-08-12 2002-09-24 Novartis Ag Long term xenogeneic myeloid and lymphoid cell production in chimeric immunocompromised mice
US7273753B2 (en) 1996-08-02 2007-09-25 Center Of Blood Research Purification and uses of dendritic cells and monocytes
CA2284689C (en) 1997-04-09 2009-10-06 Lung-Ji Chang Animal model for evaluation of vaccines
US6248721B1 (en) * 1997-04-09 2001-06-19 Lung-Ji Chang Method of using mouse model for evaluation of HIV vaccines
CA2382383A1 (en) 1999-08-31 2001-03-08 Genencor International, Inc. Transgenic mammal capable of facilitating production of donor-specific functional immunity
US20030028911A1 (en) 1999-08-31 2003-02-06 Manley Huang Transgenic mammal capable of facilitating production of donor-specific functional immunity
WO2001042484A1 (en) 1999-12-09 2001-06-14 Human Genome Sciences, Inc. Il-6 like polynucleotide
US6864061B2 (en) 2000-09-14 2005-03-08 Genetrol Biotherapeutics, Inc. Method for screening compounds for anti-inflammatory activity
US6596541B2 (en) * 2000-10-31 2003-07-22 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
US6586251B2 (en) 2000-10-31 2003-07-01 Regeneron Pharmaceuticals, Inc. Methods of modifying eukaryotic cells
AU2002363322A1 (en) 2001-10-26 2003-05-19 Large Scale Biology Corporation Endothelial cell derived hemotopoietic growth factor
EP1994824A1 (en) * 2001-11-15 2008-11-26 Kirin Pharma Kabushiki Kaisha Chimeric non-human animal
AU2003281309A1 (en) * 2002-07-05 2004-01-23 Kirin Beer Kabushiki Kaisha Novel undifferentiated stem cells contained in cord blood, bone marrow, peripheral blood or the like
CN101250553A (en) * 2002-07-13 2008-08-27 上海医学遗传研究所 Human thrombopoietin expression vector and constructing method therefor
WO2004022738A1 (en) * 2002-09-09 2004-03-18 California Institute Of Technology Methods and compositions for the generation of humanized mice
EP1418185A1 (en) 2002-11-11 2004-05-12 Aventis Pharma Deutschland GmbH Use of EDG2 receptor in an animal model of heart failure
ATE401787T1 (en) 2002-12-16 2008-08-15 Genentech Inc HUMAN CD20 EXPRESSING TRANSGENIC MICE
CN1751236A (en) 2002-12-16 2006-03-22 健泰科生物技术公司 Transgenic mice expressing human CD20
PL1802193T3 (en) 2004-10-19 2014-09-30 Regeneron Pharma Method for generating a mouse homozygous for a genetic modification
US7759541B2 (en) 2004-12-13 2010-07-20 Iti Life Sciences Transgenic animals for assessing drug metabolism and toxicity
GB2434578A (en) 2006-01-26 2007-08-01 Univ Basel Transgenic animals
ES2618787T5 (en) 2006-04-25 2022-10-21 Univ California Administration of growth factors for the treatment of CNS disorders
EP1878342A1 (en) 2006-07-13 2008-01-16 Institut Pasteur Immunodeficient mice transgenic for HLA class I and HLA class II molecules and their uses
WO2008060360A2 (en) 2006-09-28 2008-05-22 Surmodics, Inc. Implantable medical device with apertures for delivery of bioactive agents
EP2088854A1 (en) * 2006-12-05 2009-08-19 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Improved xenogenic immune system in a non-human mammal
AU2008262487B2 (en) 2007-05-23 2013-10-31 Sangamo Therapeutics, Inc. Methods and compositions for increased transgene expression
GB0718029D0 (en) * 2007-09-14 2007-10-24 Iti Scotland Ltd Two step cluster deletion and humanisation
US20110118446A1 (en) 2007-09-28 2011-05-19 The General Hospital Corporation Methods and compositions for antibody production
EP2257250A2 (en) 2008-01-29 2010-12-08 Gilbert H. Kliman Drug delivery devices, kits and methods therefor
SG176118A1 (en) 2009-06-29 2011-12-29 Qingfeng Chen Methods of producing humanized non-human mammals
EP2448967B1 (en) 2009-06-29 2015-04-15 Ilya B. Leskov Non-human mammal model of human hematopoietic cancer
RU2425880C2 (en) 2009-07-30 2011-08-10 Учреждение Российской академии наук Институт общей генетики им. Н.И. Вавилова РАН Method of producing transgene mice
DK3417701T3 (en) * 2009-10-06 2022-03-14 Regeneron Pharma GENOMIFICATED MOUSES AND INTAKING
WO2012040207A2 (en) 2010-09-20 2012-03-29 Yale University HUMAM SIRPAα TRANSGENIC ANIMALS AND THEIR METHODS OF USE
WO2012051572A1 (en) 2010-10-15 2012-04-19 Massachusetts Institute Of Technology A humanized non-human mammal model of malaria and uses thereof
EP4233537A3 (en) 2011-02-15 2023-09-13 Regeneron Pharmaceuticals, Inc. Humanized m-csf mice and uses thereof
CN108866101A (en) 2011-10-28 2018-11-23 瑞泽恩制药公司 Humanization IL-6 and IL-6 receptor
JP6283031B2 (en) 2012-09-07 2018-02-21 イエール ユニバーシティ Genetically modified non-human animals and uses thereof
RU2673156C2 (en) 2012-11-05 2018-11-22 Ридженерон Фармасьютикалз, Инк. Genetically modified non-human animals and methods for use thereof
ES2959333T3 (en) 2013-09-23 2024-02-23 Regeneron Pharma Non-human animals that have a humanized signal regulatory protein gene
DK3138397T3 (en) 2013-10-15 2019-04-15 Regeneron Pharma Humanized IL-15 animals
AU2015264427B2 (en) 2014-05-19 2021-09-23 Institute For Research In Biomedicine (Irb) Genetically modified non-human animals expressing human EPO
DK3282835T3 (en) 2015-04-13 2023-06-26 Regeneron Pharma Humanized SIRP?-IL-15 knockin mice and methods of use thereof

Also Published As

Publication number Publication date
US20170172121A1 (en) 2017-06-22
WO2011044050A2 (en) 2011-04-14
CA2776583A1 (en) 2011-04-14
HK1174783A1 (en) 2013-07-26
JP6674517B2 (en) 2020-04-01
PT3417701T (en) 2022-03-16
EP2485583A2 (en) 2012-08-15
EP3056082B1 (en) 2018-09-05
DK3417701T3 (en) 2022-03-14
JP6408497B2 (en) 2018-10-17
AU2010303737A1 (en) 2012-04-26
US8541646B2 (en) 2013-09-24
JP2016104022A (en) 2016-06-09
JP2020092712A (en) 2020-06-18
US8692052B2 (en) 2014-04-08
JP2018201521A (en) 2018-12-27
US20110200982A1 (en) 2011-08-18
WO2011044050A3 (en) 2011-06-03
US10278374B2 (en) 2019-05-07
EP3417701B1 (en) 2021-12-15
JP7050105B2 (en) 2022-04-07
EP3417701A1 (en) 2018-12-26
JP2022095741A (en) 2022-06-28
ES2700852T3 (en) 2019-02-19
US20190297862A1 (en) 2019-10-03
CA2776583C (en) 2019-06-11
EP2485583B1 (en) 2016-07-06
AU2010303737B2 (en) 2014-05-29
JP2013506433A (en) 2013-02-28
DK2485583T3 (en) 2016-10-03
US20130024957A1 (en) 2013-01-24
US9301509B2 (en) 2016-04-05
US20130022996A1 (en) 2013-01-24
US11051499B2 (en) 2021-07-06
EP4049535A1 (en) 2022-08-31
ES2908587T3 (en) 2022-05-03
EP2485583A4 (en) 2013-05-15
CA3040377A1 (en) 2011-04-14
JP5874881B2 (en) 2016-03-02
ES2591107T3 (en) 2016-11-24
US20220000084A1 (en) 2022-01-06
EP3056082A1 (en) 2016-08-17
US9554563B2 (en) 2017-01-31
US20140090095A1 (en) 2014-03-27
DK3056082T3 (en) 2018-12-17
PT3056082T (en) 2018-12-12

Similar Documents

Publication Publication Date Title
HK1174783A1 (en) Genetically modified mice and engraftment
HRP20181493T1 (en) Epsilon-polylysine conjugates and use thereof
EP2515946A4 (en) Nanoconjugates and nanoconjugate formulations
IL214403A0 (en) Novelcell lines and methods
GB0915657D0 (en) Amplifier
PT2437606T (en) Compositions and methods for increasing telomerase activity
EP2399993A4 (en) Hypo-immunogenic streptavidin and use thereof
AU329647S (en) Sofa
GB0902173D0 (en) Compounds and their use
GB0912744D0 (en) Methods and uses
GB0901494D0 (en) Compositions and Methods
GB0922510D0 (en) Compound and use
GB0911526D0 (en) Memorial
EP2470022A4 (en) Compounds and methods
GB0902399D0 (en) Attachment means and methods
GB0914464D0 (en) Animal collar-guard
GB0906993D0 (en) Combination coffin and furniture
TWM369760U (en) Urn
GB0920904D0 (en) Uses and methods
TWM373719U (en) Smoldering ovean
GB0904371D0 (en) Coffin
GB0905640D0 (en) Coffin
PL387172A1 (en) Coffin identificator
GB0914517D0 (en) Neutraceutical
GB0901964D0 (en) Co-crystals and their use